title: High expression of Rab25 contributes to malignant phenotypes and biochemical recurrence in patients with prostate cancer after radical prostatectomy.
abstract: BACKGROUND
  Ras-related protein 25 (Rab25) functions either as an oncogene or a tumor suppressor with a cancer type-dependent manner. We aimed to investigate clinical significance of Rab25 in prostate cancer (PCa).
  
  
  METHODS
  Quantitative real-time polymerase chain reaction, Western blot and immunohistochemistry were respectively performed to detect Rab25 mRNA and protein expression in PCa and adjacent non-cancerous prostate tissues. Receiver-operating characteristic curve analysis was used to evaluate predictive diagnostic value of Rab25. Associations of Rab25 expression with various clinicopathological characteristics and biochemical recurrence-free survival of PCa patients were statistically evaluated. In vitro, PCa cell proliferation was assessed by CCK-8 assay, and the cell migration and invasion activities were evaluated by Transwell assay, following the transfection of Rab25 small interfering RNA.
  
  
  RESULTS
  Ras-related protein 25 mRNA and protein expression in PCa tissues were both significantly higher than adjacent non-cancerous prostate tissues (both P < 0.001). The area under the curve of Rab25 immunoreactive score (IRS) was 0.896 (P < 0.001) with 74.0% sensitivity and 95.0% specificity. High Rab25 IRS was significantly associated with high Gleason score (P = 0.02) and distant metastasis (P = 0.01). PCa patients with high Rab25 IRS had shorter overall and biochemical recurrence-free survivals than those with low Rab25 IRS (both P < 0.001). Cox regression analysis identified Rab25 as an independent biomarker for both overall and biochemical recurrence-free survivals of PCa patients. By exploring its activities in vitro, Rab25 downregulation was found to inhibit PCa cell proliferation, migration and invasion.
  
  
  CONCLUSIONS
  High expression of Rab25 may contribute to malignant progression and biochemical recurrence of PCa patients after radical prostatectomy.
authors.affiliation: Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004 China.
authors.forename: Chunhui
authors.initials: C
authors.lastname: Hu
authors.affiliation: Department of Intensive Care Unit, Huai'an First People's Hospital, Huai'an, 223300 Jiangsu China.
authors.forename: Beibei
authors.initials: B
authors.lastname: Chen
authors.affiliation: Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004 China.
authors.forename: Yibin
authors.initials: Y
authors.lastname: Zhou
authors.affiliation: Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004 China.
authors.forename: Yuxi
authors.initials: Y
authors.lastname: Shan
keywords: Biochemical recurrence; Malignant progression; Prostate cancer; Ras-related protein 25